2026 NPPES data Retina Specialist (Ophthalmology) Physician NPI 1114366200 MD, MBA
Verify on CMS →

DANIEL GOLOGORSKY, MD, MBA

Retina Specialist (Ophthalmology) Physician in MIAMI BEACH, Florida. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
143
Medicare Part D claims · 39 beneficiaries · Retina Specialist (Ophthalmology) Physician avg: 558
Generic prescribing
41%
generic claims · 59% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
30.4123/100
▼ 53 pts below national avg 83.1 · [object Object]
Industry payments
$120.11
4 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: DANIEL GOLOGORSKY, MD, MBA is a Retina Specialist (Ophthalmology) Physician ([object Object]) practicing in MIAMI BEACH, Florida with a Medicare Part D prescribing footprint of 143 claims across 39 beneficiaries — 59% brand-name prescribing . Their CMS MIPS Final Score of 30.4123/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities . Industry payments of $120.11 across 4 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: DANIEL GOLOGORSKY, MD, MBA reported a CMS MIPS final score of 30.4123 out of 100, below the 83.1 national average, and filed 143 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

DANIEL GOLOGORSKY, MD, MBA practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

DANIEL GOLOGORSKY, MD, MBA at a glance

Below national average

NPI registry status

Active

Issued 06/21/2013

NPI 1114366200

Primary specialty

Retina Specialist (Ophthalmology) Physician

Niche

913 US NPIs in this specialty

Medicare Part D claims

143 74% vs specialty avg

2023 prescription claims

Specialty avg: 558

MIPS final score

30.4123/100 52.68769999999999% pts

Below average band

vs 83.1 national avg

Specialty distribution in Florida

How Retina Specialist (Ophthalmology) Physician compares to other specialties among Florida providers

Florida providers

Retina Specialist (Ophthalmology) Physician share within Florida

1. Retina Specialist (Ophthalmology) Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Retina Specialist (Ophthalmology) Physician share within Florida

Medicare quality performance — MIPS

DANIEL GOLOGORSKY, MD, MBA's 2023 MIPS final score plotted against the Retina Specialist (Ophthalmology) Physician national average

Below national average
MIPS Final Score
30.4123/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Retina Specialist (Ophthalmology) Physician) — 30.4123/100 vs national avg 83.1

0%100%National avg83%30.4%
MIPS final score (Retina Specialist (Ophthalmology) Physician) — 30.4123/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

DANIEL GOLOGORSKY, MD, MBA is a Retina Specialist (Ophthalmology) Physician provider practicing in MIAMI BEACH, Florida, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD, MBA. NPI: 1114366200. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

DANIEL GOLOGORSKY, MD, MBA appears in the CMS NPPES registry as a Retina Specialist (Ophthalmology) Physician provider holding MD, MBA credentials at 4308 ALTON RD STE 610, MIAMI BEACH, FL, 33140, with a listed phone of (305) 902-3200. NPI 1114366200 was issued on 06/21/2013. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what GOLOGORSKY most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 143 prescription claims written by this provider, covering 39 Medicare beneficiaries and totaling roughly $26K in drug spend, split 59% brand-name and 41% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 30.4123/100 for the 2023 performance year (Quality 6.0684, Cost 57.9082), compared with the national average of 83.1.

Retina Specialist (Ophthalmology) Physician is a narrow specialty nationwide, with 913 enrolled providers across 48 states and an average of 558 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

4308 ALTON RD STE 610
MIAMI BEACH, FL 33140

Provider Details

NPI 1114366200
Specialty Retina Specialist (Ophthalmology) Physician
Credentials MD, MBA
Gender Male
NPI Issued 06/21/2013

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

30.4123
Final Score
Avg: 83.1
6.0684
Quality
57.9082
Cost
0
Promoting Interoperability

Reporting: Group practice

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for DANIEL GOLOGORSKY, MD, MBA. Source: openpaymentsdata.cms.gov.

Total received

$120

Largest payer

Topcon Healthcare, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Florida FLDOH 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 — they are NOT specific to DANIEL GOLOGORSKY, MD, MBA. To verify DANIEL GOLOGORSKY, MD, MBA's current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases

FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Brand-heavy

DANIEL GOLOGORSKY, MD, MBA — brand share 59.0%
Specialty average (est.)

59% brand-name claims vs 41% generic, on 143 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

143
Total Claims
$26K
Total Drug Cost
39
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
217
Total Day Supply
6,040
Brand vs Generic
59% brand / 41% generic
Brand Drug Cost
$24K
Generic Drug Cost
$2K

Patient Demographics

Average Patient Age
71.8 years
Avg HCC Risk Score
1.04
Gender Split
59% female / 41% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Latanoprost
75
Dorzolamide-Timolol
Dorzolamide Hcl/Timolol Maleat
22

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Retina Specialist (Ophthalmology) Physician Overview

How DANIEL GOLOGORSKY, MD, MBA fits within the Retina Specialist (Ophthalmology) Physician landscape nationally.

913
Retina Specialist (Ophthalmology) Physician Providers in US
48
States with Retina Specialist (Ophthalmology) Physician
558
Avg Claims per Provider

DANIEL GOLOGORSKY, MD, MBA's 143 claims are below the specialty average of 558.

Nearby Retina Specialist (Ophthalmology) Physician Providers in Florida

Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as GOLOGORSKY.

Compare Retina Specialist (Ophthalmology) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is DANIEL GOLOGORSKY, MD, MBA's specialty?
DANIEL GOLOGORSKY, MD, MBA specializes in Retina Specialist (Ophthalmology) Physician and practices in MIAMI BEACH, Florida. Credentials: MD, MBA.
How much does DANIEL GOLOGORSKY, MD, MBA prescribe under Medicare Part D?
In 2023, DANIEL GOLOGORSKY, MD, MBA wrote 143 Medicare Part D claims totaling $26K in drug costs for 39 beneficiaries.
What is DANIEL GOLOGORSKY, MD, MBA's Medicare quality score?
DANIEL GOLOGORSKY, MD, MBA has a CMS MIPS Final Score of 30.4123/100 (Quality: 6.0684, Cost: 57.9082). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is DANIEL GOLOGORSKY, MD, MBA located?
DANIEL GOLOGORSKY, MD, MBA is located at 4308 ALTON RD STE 610, MIAMI BEACH, FL, 33140. Phone: (305) 902-3200.
What is DANIEL GOLOGORSKY, MD, MBA's NPI number?
DANIEL GOLOGORSKY, MD, MBA's National Provider Identifier (NPI) is 1114366200, issued on 06/21/2013.
Does DANIEL GOLOGORSKY, MD, MBA prescribe more brand-name or generic drugs?
DANIEL GOLOGORSKY, MD, MBA's prescribing is 59% brand-name and 41% generic drugs by claim count, with $24K in brand drug costs.
How many Retina Specialist (Ophthalmology) Physician providers are there in the US?
There are 913 Retina Specialist (Ophthalmology) Physician providers across 48 states in the US. The average Retina Specialist (Ophthalmology) Physician provider writes 558 Medicare Part D claims per year.
What drugs does DANIEL GOLOGORSKY, MD, MBA prescribe most often?
Based on 2023 Medicare Part D data, DANIEL GOLOGORSKY, MD, MBA's most frequently prescribed drugs include Latanoprost, Dorzolamide-Timolol. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does DANIEL GOLOGORSKY, MD, MBA accept Medicare?
DANIEL GOLOGORSKY, MD, MBA appears in CMS Medicare data with 143 Part D claims and 39 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify DANIEL GOLOGORSKY, MD, MBA's credentials?
DANIEL GOLOGORSKY, MD, MBA's NPI is 1114366200 with credentials MD, MBA. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology